Silberman David 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Silberman David
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-04+136,500→ 366,500 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.